Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05652218 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Study acronym: REINVENT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Mar 31, 2026 to Sep 30, 2026v12
  2. Primary completion date: Nov 28, 2025 to Feb 28, 2026
    • Study completion date: Dec 31, 2025 to Mar 31, 2026
    v11
  3. Primary completion date: Sep 5, 2025 to Nov 28, 2025
    • Study completion date: Oct 5, 2025 to Dec 31, 2025
    v10
  4. Primary completion date: Jun 5, 2025 to Sep 5, 2025
    • Study completion date: Jun 5, 2025 to Oct 5, 2025
    v9
  5. Primary and study completion dates: Aug 23, 2024 to Jun 5, 2025
    • Trial status: Completed to Active, Not Recruiting
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 20 to confirmed 21
    • Primary and study completion dates changed from estimate of Dec 31, 2024 to Aug 23, 2024
    v7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v6
  3. Site details revised at 1 of 2 sitesv5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 23, 2023 to Feb 26, 2023
    • Site details revised at 2 of 2 sites
    v3
  6. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024
    • Start date: Dec 23, 2022 to Feb 23, 2023
    • Study sites: 1 to 2
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary Objective - To determine if implantation of a permanent CRT pacing device (with LB-CRT, or conventional BiV-CRT with a coronary sinus LV lead) can improve electromechanical function, HF symptoms, and natriuretic peptide levels among patients with symptomatic HF, LVEF \> 35%, and LBBB.
Trial Details
NCT Number NCT05652218
Lead Sponsor Inova Health Care Services
Collaborators: Medtronic
Conditions
(from sponsor)		 Left Ventricular Ejection Fraction, Heart Failure (HF), Left Bundle-Branch Block
Related terms Bundle-Branch Block, Heart Failure
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov